Group-C meningococcal conjunctivitis in a neonate.
Meningococcal conjunctivitis, although rare, may be complicated by ocular damage and systemic spread. Identification of the infecting organism is important for appropriate management. Meningococcal infection needs treatment of both the patient and the contacts. We report the use of meningococcal group-C vaccine in the prophylaxis of adult contacts of a neonate with meningococcal conjunctivitis. This measure, we believe, has not been reported before in the management of meningococcal conjunctivitis.
Dinakaran
S
S
Department of Ophthalmology, Doncaster Royal Infirmary, Doncaster, United Kingdom. dina@thefree.net
Desai
S P
SP
D000900:Anti-Bacterial Agents; D003228:Conjunctiva / Q000382:microbiology / Q000473:pathology; D003234:Conjunctivitis, Bacterial / Q000175:diagnosis / Q000382:microbiology* / Q000628:therapy; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008589:Meningococcal Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology / Q000517:prevention & control; D022401:Meningococcal Vaccines / Q000627:therapeutic use; D009345:Neisseria meningitidis / Q000302:isolation & purification*; D009883:Ophthalmic Solutions
D000900:Anti-Bacterial Agents; D022401:Meningococcal Vaccines; D009883:Ophthalmic Solutions